Cas:188399-46-4 (1R, 3S, 4R)-ent-Entecavir manufacturer & supplier

We serve Chemical Name:(1R, 3S, 4R)-ent-Entecavir CAS:188399-46-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(1R, 3S, 4R)-ent-Entecavir

Chemical Name:(1R, 3S, 4R)-ent-Entecavir
CAS.NO:188399-46-4
Synonyms:2-amino-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-9H-purin-6-ol;SC1449;6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-;2-Amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-Purin-6-one;2-Amino-9-((1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one;2-Amino-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one;Entecavir Impurity 3
Molecular Formula:C12H15N5O3
Molecular Weight:277.279
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.8±0.1 g/cm3
Index of Refraction:1.837
PSA:130.05000
Exact Mass:277.117493
LogP:-0.96

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-amino-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-9H-purin-6-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Entecavir Impurity 3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]- Use and application,2-Amino-9-((1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one technical grade,usp/ep/jp grade.


Related News: In the trial, 362 eligible patients were randomised (1:1) and received a fixed-dose intravenous infusion of 300mg anifrolumab or placebo every four weeks. (2-{2-Chloro-4-[2-(5-chloro-benzothiazol-2-yl)-ethyl]-phenoxy}-ethyl)-diethyl-amine; hydrochloride manufacturers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. 2-((5,7-dichloro-4-(4-chlorophenyl)-3,8-dihydroxy-1-(methoxycarbonyl)-6-methyl-9-oxo-9H-xanthen-2-yl)thio)acetic acid suppliers “It’s the achievement of a dream for an Italian company, I had chills,” he told Forbes in a Zoom interview on Thursday. “For the first three or four decades, my grandfather was in start-up mode [without] making money.” Piperazine, 1-pentyl-4-(phenylmethyl)- vendor & factory.